Acquisition of Supplies and Reagents for the Inso Clinical Laboratory, Fourth Quarter 2024

BoliviaTenders notice for Acquisition of Supplies and Reagents for the Inso Clinical Laboratory, Fourth Quarter 2024. The reference ID of the tender is 110789221 and it is closing on 28 Nov 2024.

100% Secure Payments

Tender Details

  • Country: Bolivia
  • Summary: Acquisition of Supplies and Reagents for the Inso Clinical Laboratory, Fourth Quarter 2024
  • BOT Ref No: 110789221
  • Deadline: 28 Nov 2024
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: 24-0251-00-1501793-1-1
  • Purchaser's Detail :
  • Purchaser : NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH
    Maria Eugenia Mamani Mamani (Phone 2245414)

  • Description :
  • Bidders are invited to Acquisition of supplies and reagents for the inso clinical laboratory, fourth quarter 2024
    Status: Current
    Entity: National Institute of Occupational Health
    Department: La Paz
    Publication date: November 25, 2024
    Modality: Minor Contracting - CM
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
BoliviaTenders Features

BoliviaTenders Features

Fresh and verified Tenders from Bolivia. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Bolivia in your email inbox.

  Chat with us